Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis

BACKGROUND: Global glomerulosclerosis (GS) reflects chronic and irreversible nephron loss; however, its clinical interpretation is limited by age-related increases. We aimed to evaluate the prognostic value of GS using both conventional and age-adjusted approaches in patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). MATERIALS AND METHODS: In this retrospective cohort study, patients with biopsy-proven IgAN and FSGS were analyzed. GS was evaluated using both conventional measures and an age-adjusted approach based on reference values derived from healthy kidney donors. The primary outcome was defined as a ≥ 50% decline in estimated glomerular filtration rate (eGFR) or progression to end-stage kidney disease. Logistic regression and Cox proportional hazards models were used to assess associations with renal outcomes. RESULTS: A total of 218 patients were included in the final analysis, of whom 73 (33.5%) were classified as having age-adjusted excess GS. During a mean follow-up of 45.8 ± 23.8 months, 46 patients (21.1%) reached the renal endpoint. Renal events occurred significantly more frequently in patients with excess GS compared to those with expected GS (46.6 vs. 8.3%, p < 0.001). This corresponded to a significantly higher risk of renal progression in patients with excess GS (OR = 9.66, 95% CI 4.57 - 20.43, p < 0.001). In multivariable Cox analysis, excess GS remained independently associated with renal outcome (HR 5.21, 95% CI 1.97 - 13.73, p = 0.001), whereas conventional GS measures showed weaker associations. Each 10% increase in GS ratio was associated with a 24% higher risk of progression (OR 1.24, p = 0.005). Kaplan-Meier analysis demonstrated significantly worse renal survival in patients with excess GS. CONCLUSION: Age-adjusted GS is a strong and independent predictor of renal outcome in IgAN and FSGS and provides additional prognostic information beyond conventional GS measures.

Authors

Publication Details

Journal
Clinical Nephrology
Published
2026-11-18
DOI
https://doi.org/10.5414/cn112109
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis

Serkan Aktürk, Murat Duranay, Saba Kiremitçi, Ramazan Öztürk et al.
2 links
Clinical Nephrology
Renal Diseases and Glomerulopathies
article

Prognostic value of age-adjusted global glomerulosclerosis in IgA nephropathy and focal segmental glomerulosclerosis

Serkan Aktürk, Murat Duranay, Saba Kiremitçi, Ramazan Öztürk, Alper Zenger
article en

Abstract

BACKGROUND: Global glomerulosclerosis (GS) reflects chronic and irreversible nephron loss; however, its clinical interpretation is limited by age-related increases. We aimed to evaluate the prognostic value of GS using both conventional and age-adjusted approaches in patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). MATERIALS AND METHODS: In this retrospective cohort study, patients with biopsy-proven IgAN and FSGS were analyzed. GS was evaluated using both conventional measures and an age-adjusted approach based on reference values derived from healthy kidney donors. The primary outcome was defined as a ≥ 50% decline in estimated glomerular filtration rate (eGFR) or progression to end-stage kidney disease. Logistic regression and Cox proportional hazards models were used to assess associations with renal outcomes. RESULTS: A total of 218 patients were included in the final analysis, of whom 73 (33.5%) were classified as having age-adjusted excess GS. During a mean follow-up of 45.8 ± 23.8 months, 46 patients (21.1%) reached the renal endpoint. Renal events occurred significantly more frequently in patients with excess GS compared to those with expected GS (46.6 vs. 8.3%, p < 0.001). This corresponded to a significantly higher risk of renal progression in patients with excess GS (OR = 9.66, 95% CI 4.57 - 20.43, p < 0.001). In multivariable Cox analysis, excess GS remained independently associated with renal outcome (HR 5.21, 95% CI 1.97 - 13.73, p = 0.001), whereas conventional GS measures showed weaker associations. Each 10% increase in GS ratio was associated with a 24% higher risk of progression (OR 1.24, p = 0.005). Kaplan-Meier analysis demonstrated significantly worse renal survival in patients with excess GS. CONCLUSION: Age-adjusted GS is a strong and independent predictor of renal outcome in IgAN and FSGS and provides additional prognostic information beyond conventional GS measures.

Clinical Nephrology
Good health and well-being
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon